Blue Jet Healthcare Limited has announced that a conference call for analysts and investors has been scheduled for Friday, February 13, 2026, at 5:00 PM IST. The purpose of this call is to discuss the company's unaudited standalone financial results for the quarter and nine months ended December 31, 2025. The call will feature management representation from Mr. Shiven Arora (Managing Director), Mr. V.K. Singh (Chief Operating Officer), Mr. Ganesh Karuppannan (Chief Financial Officer), and Mr. Sanjay Sinha (Deputy Chief Financial Officer). Details for accessing the conference call have been provided, including universal access numbers and international toll-free numbers for various countries. Participants are requested to dial in 10 minutes prior to the scheduled time. The company, a global, science-led pharmaceutical entity operating under a CDMO business model, specializes in contrast media intermediates and high-intensity sweeteners.
